Table 3 Antimicrobial susceptibility pattern of Gram-negative bacterial isolates from DM patients at BHUTH, 2023.

From: Bacterial profile and antimicrobial susceptibility pattern of urinary tract infection among diabetic patients at Bule Hora University Teaching Hospital, Southern Ethiopia

Bacterial isolates

Antimicrobial susceptibility pattern

Pattern

NIT; N (%)

NOR; N (%)

GEN; N (%)

CRO; N (%)

CIP; N (%)

CEZ; N (%)

AMP; N (%)

AMC; N (%)

TE; N (%)

E. coli (n = 15)

S

14 (93.3)

9 (60)

11 (73.3)

10 (66.7)

11 (73.3)

7 (46.7)

0 (0)

3 (20)

4 (26.7)

I

0 (0)

1 (6.7)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

R

1 (6.7)

5 (33.3)

4 (26.7)

5 (33.3)

4 (26.7)

8 (53.3)

15 (100)

12 (80)

11 (73.3)

Klebsiella species (n = 6)

S

6 (100)

3 (50)

5 (83.3)

4 (66.7)

3 (50)

3 (50)

0 (0)

0 (0)

1 (16.7)

I

0 (0)

2 (33.3)

1 (16.7)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

R

0 (0)

1 (16.7)

0 (0)

2 (33.3)

3 (50)

3 (50)

6 (100)

6 (100)

5 (83.3)

Proteus species (n = 3)

S

NA

1 (33.3)

1 (33.3)

2 (66.7)

1 (33.3)

1 (33.3)

1 (33.3)

3 (100)

1 (33.3)

I

NA

0 (0)

0 (0)

0 (0)

0 (0)

1 (33.3)

0 (0)

0 (0)

0 (0)

R

NA

2 (66.7)

2 (66.7)

1 (33.3)

2 (66.7)

1 (33.3)

2 (66.7)

0 (0)

2 (66.7)

P. aeruginosa (n = 4)

S

1 (25)

1 (25)

4 (100)

3 (75)

2 (50)

1 (25)

1 (25)

0 (0)

1 (25)

I

1 (25)

0 (0)

0 (0)

0 (0)

0 (0)

1 (25)

0 (0)

0 (0)

1 (25)

R

2 (50)

3 (75)

0 (0)

1 (25)

2 (50)

2 (50)

3 (75)

4 (100)

2 (50)

Enterobacter (n = 1)

S

1 (100)

0 (0)

1 (100)

1 (100)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

I

0 (0)

0 (0%)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0)

0 (0

R

0 (0)

1 (100)

0 (0)

0 (0)

1 (100)

1 (100)

1 (100)

1 (100)

1 (100)

Total (n = 29)

S

24 (82.76)

14 (48.3)

22 (75.9)

20 (68.9)

17 (58.6)

12 (41.4)

2 (6.9)

6 (20.7)

7 (24.14)

R

5 (17.86)

15 (51.7)

7 (24.1)

9 (31.1)

12 (41.4)

17 (58.6)

27 (93.1)

23 (79.3)

22 (75.86)

  1. AMP, ampicillin; AMC, amoxicillin-clavulanic acid; CEZ, ceftazidime; CIP, ciprofloxacin; CRO, ceftriaxone; GEN, gentamicin; I, intermediate; not applicable; NIT, nitrofurantoin; NOR, norfloxacin; N, number; %, percent; R, resistant; S, susceptible; TE, tetracycline.